Showing results (1-10 of 69) with videos related to
Sort By:
Pageof 7
FEBS Letters|November 21, 2007
Differences in the substrate binding sites of murine and human proteinase 3 and neutrophil elastaseEric Hajjar, Brice Korkmaz, Nathalie ReuterBiochimie|November 21, 2007
Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functionsBrice Korkmaz, Thierry Moreau, Francis GauthierInternational Immunopharmacology|July 27, 2013
Relevance of the mouse model as a therapeutic approach for neutrophil proteinase 3-associated human diseasesBrice Korkmaz, Dieter E Jenne, Francis GauthierFrontiers in Immunology|January 1, 2024
Dipeptidyl peptidase 1 inhibition as a potential therapeutic approach in neutrophil-mediated inflammatory diseaseJames D Chalmers, Ralph Kettritz, Brice KorkmazBiochimie|March 17, 2019
Proteinase 3 phosphonic inhibitorsRenata Grzywa, Adam Lesner, Brice Korkmaz, et al.Current Pharmaceutical Design|September 29, 2012
Selective inhibitors of human neutrophil proteinase 3Brice Korkmaz, Christine Kellenberger, Marie-Claude Viaud-Massuard, et al.Pharmacological Reviews|November 17, 2010
Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseasesBrice Korkmaz, Marshall S Horwitz, Dieter E Jenne, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2005
Inhibition of neutrophil elastase by alpha1-protease inhibitor at the surface of human polymorphonuclear neutrophilsBrice Korkmaz, Sylvie Attucci, Marie-Lise Jourdan, et al.The Journal of Biological Chemistry|October 16, 2008
A hydrophobic patch on proteinase 3, the target of autoantibodies in Wegener granulomatosis, mediates membrane binding via NB1 receptorsBrice Korkmaz, Angelika Kuhl, Behnaz Bayat, et al.American Journal of Respiratory Cell and Molecular Biology|December 25, 2003
Design and use of highly specific substrates of neutrophil elastase and proteinase 3Brice Korkmaz, Sylvie Attucci, Thierry Moreau, et al.Pageof 7